83 FR 47879 - Sodium Gluconate, Gluconic Acid and Derivative Products From the People's Republic of China: Final Affirmative Countervailing Duty Determination
DEPARTMENT OF COMMERCE
International Trade Administration Federal Register Volume 83, Issue 184 (September 21, 2018)
International Trade Administration
Federal Register Volume 83, Issue 184 (September 21, 2018)
| Page Range | 47879-47880 | |
| FR Document | 2018-20605 |
[Federal Register Volume 83, Number 184 (Friday, September 21, 2018)] [Notices] [Pages 47879-47880] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-20605] ----------------------------------------------------------------------- DEPARTMENT OF COMMERCE International Trade Administration [C-570-072] Sodium Gluconate, Gluconic Acid and Derivative Products From the People's Republic of China: Final Affirmative Countervailing Duty Determination AGENCY: Enforcement and Compliance, International Trade Administration, Department of Commerce. SUMMARY: The Department of Commerce (Commerce) determines that countervailable subsidies are being provided to producers and exporters of sodium gluconate, gluconic acid and derivative products from the People's Republic of China (China). DATES: Applicable September 21, 2018. FOR FURTHER INFORMATION CONTACT: Robert Galantucci or Jonathan Hill, AD/CVD Operations, Office IV, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce, 1401 Constitution Avenue NW, Washington, DC 20230; telephone (202) 482-2923 or (202) 482- 3518, respectively. SUPPLEMENTARY INFORMATION: Background This final determination is made in accordance with section 705 of the Tariff Act of 1930, as amended (the Act). The petitioner in this investigation is PMP Fermentation Products, Inc. (the petitioner). The mandatory respondents in this investigation are Qingdao Dongxiao Enterprise Co., Ltd. (Qingdao Dongxiao), Shandong Fuyang Biotechnology Co. (Fuyang), Shandong Kaison Biochemical Co Ltd (Kaison), and Tongxiang Hongyu Chemical Co., Ltd. (Hongyu Chemical). Hongyu Chemical, Kaison, and Qingdao Dongxiao did not respond to any of our requests for information. We published our Preliminary Determination on May 23, 2018.\1\ On May 30, 2018, Fuyang, the sole respondent to provide a questionnaire response in this investigation, notified Commerce that it would no longer be participating in the proceeding.\2\ On June 21, 2018, the petitioner submitted a case brief.\3\ We received no comments from other interested parties. --------------------------------------------------------------------------- \1\ See Sodium Gluconate, Gluconic Acid, and Derivative Products from the People's Republic of China: Preliminary Affirmative Countervailing Duty Determination and Alignment of Final Determination with Final Antidumping Duty Determination, 83 FR 23888 (May 23, 2018) (Preliminary Determination) and accompanying Preliminary Decision Memorandum. \2\ See Letter from Fuyang, ``Countervailing Duty Investigation on Sodium Gluconate, Gluconic Acid, and Derivative Products from the People's Republic of China: Notice of Non-Participation in Investigation,'' dated May 30, 2018. \3\ See Letter from the petitioner, ``Countervailing Duty Investigation of Sodium Gluconate, Gluconic Acid and Derivative Products from the People's Republic of China: Petitioner's Case Brief,'' dated June 21, 2018. --------------------------------------------------------------------------- Additional background on this case, including a summary of events that occurred since Commerce published the Preliminary Determination, and a discussion of comments from the petitioner, are provided in the Issues and Decision Memorandum, which is hereby adopted by this notice.\4\ The Issues and Decision Memorandum is a public document and is on file electronically via Enforcement and Compliance's Antidumping and Countervailing Duty Centralized Electronic Service System (ACCESS). ACCESS is available to registered users at https://access.trade.gov and is available to all parties in the Central Records Unit, room B8024 of the main Department of Commerce building. In addition, a complete version of the Issues and Decision Memorandum can be accessed directly at http://enforcement.trade.gov. The signed and electronic versions of the Issues and Decision Memorandum are identical in content. --------------------------------------------------------------------------- \4\ See Memorandum, ``Issues and Decision Memorandum for the Final Affirmative Determination in the Countervailing Duty Investigation of Sodium Gluconate, Gluconic Acid and Derivative Products from the People's Republic of China,'' dated concurrently with, and hereby adopted by, this notice (Issues and Decision Memorandum). --------------------------------------------------------------------------- Scope of the Investigation The products covered by this investigation are sodium gluconate, gluconic acid, and derivative products from China. We have made no changes to the scope of the investigation, as published in the Preliminary Determination.\5\ For a complete description of the scope of this investigation, see Appendix I to this notice. --------------------------------------------------------------------------- \5\ See 83 FR at 23888 (noting that Commerce would consider scope comments from interested parties and implement any changes to the scope in the final countervailing duty determination). --------------------------------------------------------------------------- Period of Investigation The period of investigation is January 1, 2016, through December 31, 2016. Analysis of Comments Received All issues raised in the case brief submitted by the petitioner are addressed in the Issues and Decision Memorandum accompanying this notice. A list of the issues addressed in the memorandum is attached to this notice at Appendix II. Adverse Facts Available In this final determination, we continue to apply facts available with an adverse inference to Fuyang, Hongyu Chemical, Kaison, and Qingdao Dongxiao. For purposes of this final determination, we relied on facts available and, because the respondents did not respond, or did not act to the best of their ability in responding to, our requests for information, we drew adverse inferences in selecting from among the facts otherwise available, pursuant to sections 776(a)-(b) of the Act.\6\ A detailed discussion of our application of adverse facts available was provided in the Preliminary Decision Memorandum accompanying our Preliminary Determination, and additional discussion is contained in the Issues and Decision Memorandum accompanying this notice. --------------------------------------------------------------------------- \6\ See sections 776(a) and (b) of the Act. Section 782(i) of the Act requires Commerce to verify a respondent's data as part of an investigation. However, because we applied adverse facts available to each of the respondents in the Preliminary Determination, we did not conduct verification in this investigation. --------------------------------------------------------------------------- Changes Since the Preliminary Determination In our Preliminary Determination, we applied adverse facts available to calculate the subsidy rates for all mandatory respondents. We have made no changes to our analysis, or to the respondents' subsidy rates, for this final determination. Final Determination With respect to the ``all-others'' rate, section 705(c)(5)(A)(ii) of the Act provides that if the countervailing duty rates established for all exporters and producers individually investigated are determined entirely in accordance with section 776 of the Act, Commerce may use any reasonable method to establish an all-others rate for exporters and producers not individually investigated. In this case, the rates assigned to Fuyang, Hongyu Chemical, Kaison, and [[Page 47880]] Qingdao Dongxiao are based entirely on facts otherwise available, with adverse inferences, under section 776 of the Act. Because there is no other information on the record with which to determine an all-others rate, in accordance with section 705(c)(5)(A)(ii) of the Act, we have established the all-others rate by applying the countervailable subsidy rates for mandatory respondents Fuyang, Hongyu Chemical, Kaison, and Qingdao Dongxiao. The final countervailable subsidy rates are summarized in the table below. ------------------------------------------------------------------------ Subsidy rate Producer/exporter (percent) ------------------------------------------------------------------------ Qingdao Dongxiao Enterprise Co., Ltd.................... 194.67 Shandong Fuyang Biotechnology Co........................ 194.67 Shandong Kaison Biochemical Co Ltd...................... 194.67 Tongxiang Hongyu Chemical Co., Ltd...................... 194.67 All-Others.............................................. 194.67 ------------------------------------------------------------------------ Disclosure We described the subsidy rate calculations, which were based on adverse facts available, in the Preliminary Decision Memorandum. As noted above, there are no changes to our calculations. Thus, no additional disclosure is necessary for this final determination. Continuation of Suspension of Liquidation As a result of our Preliminary Determination and pursuant to section 703(d) of the Act, we instructed U.S. Customs and Border Protection (CBP) to suspend liquidation of any entries of merchandise under consideration from China that were entered, or withdrawn from warehouse, for consumption on or after May 23, 2018, the date of the publication of the Preliminary Determination in the Federal Register. Additionally, at that time, we instructed CBP to collect cash deposits of estimated countervailing duties at the rates assigned in the Preliminary Determination. The suspension of liquidation and collection of cash deposits remains in effect until further notice.\7\ --------------------------------------------------------------------------- \7\ Provisional measures will expire on September 19, 2018, having been in effect for 120 days. Accordingly, we will direct CBP to discontinue suspension of liquidation of merchandise entered on or after September 20, 2018. If the ITC issues an affirmative final determination, we will direct CBP to resume suspension of liquidation effective on the date of publication of the ITC final determination in the Federal Register. --------------------------------------------------------------------------- If the U.S. International Trade Commission (ITC) issues a final affirmative injury determination, we will issue a countervailing duty order, will reinstate the suspension of liquidation under section 706(a) of the Act, and will require a cash deposit of estimated countervailing duties for entries of subject merchandise in the amounts indicated above. If the ITC determines that material injury, or threat of material injury, does not exist, this proceeding will be terminated, and all estimated duties deposited as a result of the suspension of the suspension of liquidation will be refunded. ITC Notification In accordance with section 705(d) of the Act, we will notify the ITC of our determination. In addition, we are making available to the ITC all non-privileged and non-proprietary information relating to this investigation. We will allow the ITC access to all privileged and business proprietary information in our files, provided the ITC confirms that it will not disclose such information, either publicly or under an administrative protective order (APO), without the written consent of the Acting Assistant Secretary for Enforcement and Compliance. Notification Regarding APOs This notice serves as a reminder to parties to an APO of their responsibility concerning the disposition of proprietary information disclosed under APO in accordance with 19 CFR 351.305(a)(3). Timely written notification of the return or destruction of APO materials or, alternatively, conversion to judicial protective order, is hereby requested. Failure to comply with the regulations and terms of an APO is a violation that is subject to sanction. Notification to Interested Parties This determination is published pursuant to section 705(d) and 777(i) of the Act and 19 CFR 351.210(c). Dated: September 17, 2018. Gary Taverman, Deputy Assistant Secretary for Antidumping and Countervailing Duty Operations, performing the non-exclusive functions and duties of the Assistant Secretary for Enforcement and Compliance. Appendix I Scope of the Investigation The scope of this investigation covers all grades of sodium gluconate, gluconic acid, liquid gluconate, and glucono delta lactone (GDL) (collectively, GNA products), regardless of physical form (including, but not limited to substrates; solutions; dry granular form or powders, regardless of particle size; or as a slurry). The scope also includes GNA products that have been blended or are in solution with other product(s) where the resulting mix contains 35 percent or more of sodium gluconate, gluconic acid, liquid gluconate, and/or GDL by dry weight. Sodium gluconate has a molecular formula of NaC6 H11 O7 . Sodium gluconate has a Chemical Abstract Service (CAS) registry number of 527-07-1, and can also be called ``sodium salt of gluconic acid'' and/or sodium 2, 3, 4, 5, 6 pentahydroxyhexanoate. Gluconic acid has a molecular formula of C6 H12 O7 . Gluconic acid has a CAS registry number of 526-95-4, and can also be called 2, 3, 4, 5, 6 pentahydroxycaproic acid. Liquid gluconate is a blend consisting only of gluconic acid and sodium gluconate in an aqueous solution. Liquid gluconate has CAS registry numbers of 527-07-1, 526-95-4, and 7732-18-5, and can also be called 2, 3, 4, 5, 6-pentahydroxycaproic acid-hexanoate. GDL has a molecular formula of C6 H10 O6 . GDL has a CAS registry number of 90-80-2, and can also be called d-glucono-1,5-lactone. The merchandise covered by the scope of this investigation is currently classified in the Harmonized Tariff Schedule of the United States (HTSUS) under subheadings 2918.16.1000, 2918.16.5010, and 2932.20.5020. Merchandise covered by the scope may also enter under HTSUS subheadings 2918.16.5050, 3824.99.2890, and 3824.99.9295. Although the HTSUS subheadings and CAS registry numbers are provided for convenience and customs purposes, the written description of the merchandise is dispositive. Appendix II List of Topics Discussed in the Issues and Decision Memorandum I. Summary II. Background III. Scope of the Investigation IV. Use of Facts Otherwise Available and Adverse Inferences V. Analysis of Comments Comment 1: Application of Total Adverse Facts Available to Hongyu Chemical, Kaison, and Qingdao Dongxiao Comment 2: Application of Total Adverse Facts Available to Fuyang Comment 3: Whether the Scope of the Investigation Should be Modified VI. Recommendation [FR Doc. 2018-20605 Filed 9-20-18; 8:45 am] BILLING CODE 3510-DS-P
![Federal Register / Vol. 83, No. 184 / Friday, September 21, 2018 / Notices 47879
V. Discussion of the Issues May 30, 2018, Fuyang, the sole investigation, see Appendix I to this
Comment 1: Application of Adverse Facts respondent to provide a questionnaire notice.
Available (AFA) to the China-wide response in this investigation, notified
Entity Period of Investigation
Commerce that it would no longer be
Comment 2: Whether to Assign the China-
participating in the proceeding.2 On The period of investigation is January
Wide Entity Rate to the Separate Rate
Applicant June 21, 2018, the petitioner submitted 1, 2016, through December 31, 2016.
Comment 3: Whether the Scope of the a case brief.3 We received no comments Analysis of Comments Received
Investigation Should be Modified from other interested parties.
VI. Recommendation All issues raised in the case brief
Additional background on this case, submitted by the petitioner are
[FR Doc. 2018–20606 Filed 9–20–18; 8:45 am] including a summary of events that addressed in the Issues and Decision
BILLING CODE 3510–DS–P occurred since Commerce published the Memorandum accompanying this
Preliminary Determination, and a notice. A list of the issues addressed in
discussion of comments from the the memorandum is attached to this
DEPARTMENT OF COMMERCE petitioner, are provided in the Issues notice at Appendix II.
and Decision Memorandum, which is
International Trade Administration Adverse Facts Available
hereby adopted by this notice.4 The
[C–570–072] Issues and Decision Memorandum is a In this final determination, we
public document and is on file continue to apply facts available with an
Sodium Gluconate, Gluconic Acid and electronically via Enforcement and adverse inference to Fuyang, Hongyu
Derivative Products From the People’s Compliance’s Antidumping and Chemical, Kaison, and Qingdao
Republic of China: Final Affirmative Countervailing Duty Centralized Dongxiao. For purposes of this final
Countervailing Duty Determination Electronic Service System (ACCESS). determination, we relied on facts
AGENCY: Enforcement and Compliance, ACCESS is available to registered users available and, because the respondents
International Trade Administration, at https://access.trade.gov and is did not respond, or did not act to the
Department of Commerce. available to all parties in the Central best of their ability in responding to, our
SUMMARY: The Department of Commerce
Records Unit, room B8024 of the main requests for information, we drew
(Commerce) determines that Department of Commerce building. In adverse inferences in selecting from
countervailable subsidies are being addition, a complete version of the among the facts otherwise available,
provided to producers and exporters of Issues and Decision Memorandum can pursuant to sections 776(a)–(b) of the
sodium gluconate, gluconic acid and be accessed directly at http:// Act.6 A detailed discussion of our
derivative products from the People’s enforcement.trade.gov. The signed and application of adverse facts available
Republic of China (China). electronic versions of the Issues and was provided in the Preliminary
Decision Memorandum are identical in Decision Memorandum accompanying
DATES: Applicable September 21, 2018.
content. our Preliminary Determination, and
FOR FURTHER INFORMATION CONTACT: additional discussion is contained in
Robert Galantucci or Jonathan Hill, AD/ Scope of the Investigation
the Issues and Decision Memorandum
CVD Operations, Office IV, Enforcement accompanying this notice.
The products covered by this
and Compliance, International Trade
investigation are sodium gluconate, Changes Since the Preliminary
Administration, U.S. Department of
gluconic acid, and derivative products Determination
Commerce, 1401 Constitution Avenue
from China. We have made no changes
NW, Washington, DC 20230; telephone In our Preliminary Determination, we
to the scope of the investigation, as
(202) 482–2923 or (202) 482–3518, applied adverse facts available to
published in the Preliminary
respectively. calculate the subsidy rates for all
Determination.5 For a complete
SUPPLEMENTARY INFORMATION: description of the scope of this mandatory respondents. We have made
no changes to our analysis, or to the
Background respondents’ subsidy rates, for this final
Determination and Alignment of Final
This final determination is made in Determination with Final Antidumping Duty determination.
accordance with section 705 of the Determination, 83 FR 23888 (May 23, 2018)
Final Determination
Tariff Act of 1930, as amended (the Act). (Preliminary Determination) and accompanying
Preliminary Decision Memorandum. With respect to the ‘‘all-others’’ rate,
The petitioner in this investigation is 2 See Letter from Fuyang, ‘‘Countervailing Duty
PMP Fermentation Products, Inc. (the Investigation on Sodium Gluconate, Gluconic Acid,
section 705(c)(5)(A)(ii) of the Act
petitioner). The mandatory respondents and Derivative Products from the People’s Republic provides that if the countervailing duty
in this investigation are Qingdao of China: Notice of Non-Participation in rates established for all exporters and
Investigation,’’ dated May 30, 2018. producers individually investigated are
Dongxiao Enterprise Co., Ltd. (Qingdao 3 See Letter from the petitioner, ‘‘Countervailing
Dongxiao), Shandong Fuyang determined entirely in accordance with
Duty Investigation of Sodium Gluconate, Gluconic
Biotechnology Co. (Fuyang), Shandong Acid and Derivative Products from the People’s section 776 of the Act, Commerce may
Kaison Biochemical Co Ltd (Kaison), Republic of China: Petitioner’s Case Brief,’’ dated use any reasonable method to establish
and Tongxiang Hongyu Chemical Co., June 21, 2018. an all-others rate for exporters and
4 See Memorandum, ‘‘Issues and Decision
Ltd. (Hongyu Chemical). Hongyu producers not individually investigated.
Memorandum for the Final Affirmative
Chemical, Kaison, and Qingdao Determination in the Countervailing Duty
In this case, the rates assigned to
Fuyang, Hongyu Chemical, Kaison, and
daltland on DSKBBV9HB2PROD with NOTICES
Dongxiao did not respond to any of our Investigation of Sodium Gluconate, Gluconic Acid
requests for information. and Derivative Products from the People’s Republic
of China,’’ dated concurrently with, and hereby 6 See sections 776(a) and (b) of the Act. Section
We published our Preliminary adopted by, this notice (Issues and Decision 782(i) of the Act requires Commerce to verify a
Determination on May 23, 2018.1 On Memorandum). respondent’s data as part of an investigation.
5 See 83 FR at 23888 (noting that Commerce However, because we applied adverse facts
1 See Sodium Gluconate, Gluconic Acid, and would consider scope comments from interested available to each of the respondents in the
Derivative Products from the People’s Republic of parties and implement any changes to the scope in Preliminary Determination, we did not conduct
China: Preliminary Affirmative Countervailing Duty the final countervailing duty determination). verification in this investigation.
VerDate Sep<11>2014 17:30 Sep 20, 2018 Jkt 244001 PO 00000 Frm 00006 Fmt 4703 Sfmt 4703 E:\FR\FM\21SEN1.SGM 21SEN1](https://thefederalregister.org/doc/83_FR_48063/page/1.svg)
![47880 Federal Register / Vol. 83, No. 184 / Friday, September 21, 2018 / Notices
Qingdao Dongxiao are based entirely on affirmative injury determination, we particle size; or as a slurry). The scope also
facts otherwise available, with adverse will issue a countervailing duty order, includes GNA products that have been
inferences, under section 776 of the Act. will reinstate the suspension of blended or are in solution with other
Because there is no other information on liquidation under section 706(a) of the product(s) where the resulting mix contains
the record with which to determine an Act, and will require a cash deposit of 35 percent or more of sodium gluconate,
all-others rate, in accordance with estimated countervailing duties for gluconic acid, liquid gluconate, and/or GDL
section 705(c)(5)(A)(ii) of the Act, we entries of subject merchandise in the by dry weight.
have established the all-others rate by amounts indicated above. If the ITC Sodium gluconate has a molecular formula
applying the countervailable subsidy determines that material injury, or of NaC6H11O7. Sodium gluconate has a
rates for mandatory respondents threat of material injury, does not exist, Chemical Abstract Service (CAS) registry
Fuyang, Hongyu Chemical, Kaison, and this proceeding will be terminated, and number of 527–07–1, and can also be called
Qingdao Dongxiao. The final all estimated duties deposited as a result ‘‘sodium salt of gluconic acid’’ and/or
countervailable subsidy rates are of the suspension of the suspension of sodium 2, 3, 4, 5, 6 pentahydroxyhexanoate.
summarized in the table below. liquidation will be refunded. Gluconic acid has a molecular formula of
C6H12O7. Gluconic acid has a CAS registry
Subsidy rate
ITC Notification number of 526–95–4, and can also be called
Producer/exporter 2, 3, 4, 5, 6 pentahydroxycaproic acid. Liquid
(percent) In accordance with section 705(d) of
the Act, we will notify the ITC of our gluconate is a blend consisting only of
Qingdao Dongxiao Enter- determination. In addition, we are gluconic acid and sodium gluconate in an
prise Co., Ltd .................... 194.67 aqueous solution. Liquid gluconate has CAS
Shandong Fuyang Bio-
making available to the ITC all non-
privileged and non-proprietary registry numbers of 527–07–1, 526–95–4, and
technology Co ................... 194.67 7732–18–5, and can also be called 2, 3, 4, 5,
Shandong Kaison Bio- information relating to this
investigation. We will allow the ITC 6-pentahydroxycaproic acid-hexanoate. GDL
chemical Co Ltd ................ 194.67
Tongxiang Hongyu Chemical access to all privileged and business has a molecular formula of C6H10O6. GDL has
Co., Ltd ............................. 194.67 proprietary information in our files, a CAS registry number of 90–80–2, and can
All-Others .............................. 194.67 provided the ITC confirms that it will also be called d-glucono-1,5-lactone.
The merchandise covered by the scope of
not disclose such information, either
Disclosure this investigation is currently classified in
publicly or under an administrative
the Harmonized Tariff Schedule of the
We described the subsidy rate protective order (APO), without the
United States (HTSUS) under subheadings
calculations, which were based on written consent of the Acting Assistant
2918.16.1000, 2918.16.5010, and
adverse facts available, in the Secretary for Enforcement and
2932.20.5020. Merchandise covered by the
Preliminary Decision Memorandum. As Compliance.
scope may also enter under HTSUS
noted above, there are no changes to our Notification Regarding APOs subheadings 2918.16.5050, 3824.99.2890,
calculations. Thus, no additional and 3824.99.9295. Although the HTSUS
disclosure is necessary for this final This notice serves as a reminder to
parties to an APO of their responsibility subheadings and CAS registry numbers are
determination. provided for convenience and customs
concerning the disposition of
Continuation of Suspension of purposes, the written description of the
proprietary information disclosed under
Liquidation merchandise is dispositive.
APO in accordance with 19 CFR
As a result of our Preliminary 351.305(a)(3). Timely written
Appendix II
Determination and pursuant to section notification of the return or destruction
703(d) of the Act, we instructed U.S. of APO materials or, alternatively, List of Topics Discussed in the Issues and
Customs and Border Protection (CBP) to conversion to judicial protective order, Decision Memorandum
suspend liquidation of any entries of is hereby requested. Failure to comply
with the regulations and terms of an I. Summary
merchandise under consideration from II. Background
China that were entered, or withdrawn APO is a violation that is subject to
III. Scope of the Investigation
from warehouse, for consumption on or sanction.
IV. Use of Facts Otherwise Available and
after May 23, 2018, the date of the Notification to Interested Parties Adverse Inferences
publication of the Preliminary V. Analysis of Comments
This determination is published
Determination in the Federal Register. Comment 1: Application of Total Adverse
pursuant to section 705(d) and 777(i) of
Additionally, at that time, we instructed Facts Available to Hongyu Chemical,
the Act and 19 CFR 351.210(c).
CBP to collect cash deposits of Kaison, and Qingdao Dongxiao
estimated countervailing duties at the Dated: September 17, 2018. Comment 2: Application of Total Adverse
rates assigned in the Preliminary Gary Taverman, Facts Available to Fuyang
Determination. The suspension of Deputy Assistant Secretary for Antidumping Comment 3: Whether the Scope of the
liquidation and collection of cash and Countervailing Duty Operations, Investigation Should be Modified
deposits remains in effect until further performing the non-exclusive functions and VI. Recommendation
notice.7 duties of the Assistant Secretary for
Enforcement and Compliance. [FR Doc. 2018–20605 Filed 9–20–18; 8:45 am]
If the U.S. International Trade
BILLING CODE 3510–DS–P
Commission (ITC) issues a final Appendix I
daltland on DSKBBV9HB2PROD with NOTICES
7 Provisional measures will expire on September Scope of the Investigation
19, 2018, having been in effect for 120 days. The scope of this investigation covers all
Accordingly, we will direct CBP to discontinue
grades of sodium gluconate, gluconic acid,
suspension of liquidation of merchandise entered
on or after September 20, 2018. If the ITC issues an
liquid gluconate, and glucono delta lactone
affirmative final determination, we will direct CBP (GDL) (collectively, GNA products),
to resume suspension of liquidation effective on the regardless of physical form (including, but
date of publication of the ITC final determination not limited to substrates; solutions; dry
in the Federal Register. granular form or powders, regardless of
VerDate Sep<11>2014 17:30 Sep 20, 2018 Jkt 244001 PO 00000 Frm 00007 Fmt 4703 Sfmt 9990 E:\FR\FM\21SEN1.SGM 21SEN1](https://thefederalregister.org/doc/83_FR_48063/page/2.svg)
Document Created: 2018-09-21 00:23:40
Document Modified: 2018-09-21 00:23:40
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | Applicable September 21, 2018. | |
| Contact | Robert Galantucci or Jonathan Hill, AD/CVD Operations, Office IV, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce, 1401 Constitution Avenue NW, Washington, DC 20230; telephone (202) 482-2923 or (202) 482- 3518, respectively. | |
| FR Citation | 83 FR 47879 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR